30 closest matches · ranked by relevance
Congenital Nasolacrimal Duct Obstruction
Primary: Change in Physician-rated Scale of NLDO From Baseline to Follow-Up Visit at Week 8 or From Baseline to Time of Treatment Failure, if Earlier. — 7; 10; 1; 1 participants
Nasolacrimal Duct Obstruction
Primary: Proportion of Participants With Treatment Success — 0.92; 0.82 proportion of participants — p=0.09
Dry Eye Syndromes · Keratoconjunctivitis Sicca
Primary: Stimulated Acute Tear Production — 17.28; 7.92 Scores on a scale
Dry Eye Syndromes
Primary: Change From Pre-Application to Post-Application in the Ora Calibra Ocular Discomfort Scale (ODS) Score — -1.1; -0.4 score on a scale — p=0.008
Dry Eye Syndromes
Primary: Investigators' Evaluation of the Tear Lake; Comparison of Baseline Result to 7 Days — 129 mean percent change from baseline
Dry Eye Syndrome · Keratoconjunctivitis Sicca
Primary: Acute Stimulated Tear Production — 25.3; 9.2; 9.5 mm
Dry Eye · Dry Eye Syndromes · Keratoconjunctivitis Sicca
Primary: Acute Tear Production by Jones Schirmer Test
Rhinitis + Sinusitis, Pediatric Chronic Rhinosinusitis
Primary: Quality of Life (QoL) Outcomes Between Adenoidectomy + Maxillary Sinus Irrigation With or Without the Use of Balloon Dilation or Maxillary Sinus Ostia. — 2.48; 2.5…
Cerebrotendinous Xanthomatosis (CTX)
Primary: Number of Participants Who Had Positive Genetic Test Results — 4 Participants
Dry Eye Syndrome · Keratoconjunctivitis Sicca
Primary: Tear Meniscus Height Captured by Optical Coherence Tomography — 238.4; 634.9 µm
Chronic Allergic Conjunctivitis
Primary: Ocular Itching — 1.80; 2.58; 1.72; 2.70 units on a scale (0 -4)
Chronic Allergic Conjunctivitis
Primary: Ocular Itching Post-CAC (Conjunctival Allergen Challenge) at Visit 6 — 1.68; 2.66 units on a scale
Cystinosis
Primary: Number of Participants With Serious and Non-Serious Adverse Events — 257 participants
Nonalcoholic Fatty Liver Disease (NAFLD)
Primary: Improvement in Nonalcoholic Fatty Liver Disease (NAFLD) — 25; 18 participants — p=0.34
Sinusitis
Primary: Technical Success: Sinuses Successfully Treated With Balloon Dilation — 157 sinus dilation attempts
Deglutition Disorders · Respiratory Distress Syndrome In Premature Infants · Respiratory Aspiration
Primary: Pharyngeal Phase Dysphagia — 7; 7 Participants
Nasal Obstruction
Primary: Improvement in NOSE Score — 54.8 units on a scale — p=<0.0001
Chronic Allergic Conjunctivitis
Primary: Ocular Itching Post-CAC (Conjunctival Allergen Challenge) at Visit 6 — 2.04; 2.31 units on a scale
Allergic Conjunctivitis
Primary: Ocular Itching Post-CAC (Conjunctival Allergen Challenge) at Visit 6 (7 Days Post-insertion) — 1.80; 2.69 units on a scale
Chronic Rhinitis
Primary: Change in Reflective Total Nasal Symptom Score (rTNSS) — -5.1 units on a scale — p=<0.0001
Dry Eye Disease
Primary: Mean Change in Goblet Cell Area — -38.8; -6.7 um
Dry Eye Syndromes
Primary: Change From Pre-Application to Post-Application in Eye Dryness Score (EDS) Using a Visual Analog Scale (VAS) — -16.48; -3.12 score on a scale — p=<0.0001
Dry Eye Syndromes
Primary: Fluorescein Tear Clearance With Application
Infantile Neronal Ceroid Lipofuscinosis
Primary: Change in Cellular Granular Osmiophilic Deposits (GRODs) in Electron Micrographs of Peripheral White Blood Cells. — -0.3317 Average number of GRODs
Congenital Diaphragmatic Hernia
Primary: Proportion of Infants Who Are Intubated Prior to Umbilical Cord Clamping — 17 Participants
Chalazion Unspecified Eye, Unspecified Eyelid · Chalazion Left Eye, Unspecified Eyelid · Chalazion Right Eye, Unspecified Eyelid
Primary: Number of Participants With Complete Resolution — 13; 12; 11 participants
Glaucoma · Ocular Hypertension
Primary: Change From Baseline to Last Available Observation in Best Corrected Visual Acuity (BCVA) (Snellen or Equivalent) — 0.25; -0.07; 0.01; 0.04 logMar — p=0.1126
Chronic Rhinitis
Primary: Number of Participants With Procedure-related Serious Adverse Events (SAEs) and/or Serious Adverse Device Effects (SADE) — 0 Participants
Infant, Newborn · Infant, Low Birth Weight · Infant, Small for Gestational Age
Primary: Death or Neurodevelopmental Impairment (NDI) — 44; 46; 27; 28 Participants — p=0.03
Nasal Obstruction
Primary: Change in Peak Nasal Inspiratory Flow (PNIF) — 28; 24; 13; 27 liters per minute